Drug comparisons
Glimepiride vs Vildagliptin
Glimepiride (sulfonylurea) stimulates insulin release; Vildagliptin (DPP-4 inhibitor) enhances incretins for type 2 diabetes, Glimepiride risks more hypoglycemia than Vildagliptin.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes inadequately controlled on metformin monotherapy may be considering adding or switching to Glimepiride or Vildagliptin.
Bottom line
Both Glimepiride and Vildagliptin are viable options for managing type 2 diabetes, but the optimal choice varies by individual patient characteristics.
All medication comparisons